The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
The Platelet Lifeline to Cancer: Challenges and Opportunities
Open accessAbstract
SUMMARY Besides their function in limiting blood loss and promoting wound healing, experimental evidence has highlighted platelets as active players in all steps of tumorigenesis including tumor growth, tumor cell extravasation and metastasis. Additionally, thrombocytosis in cancer patients is associated with adverse patient survival. Due to the secretion of large amounts of microparticles and exosomes, platelets are well positioned to coordinate both local and distant tumor-host crosstalk. Here, we present a review of recent discoveries in the field of platelet biology and the role of platelets in cancer progression as well as challenges in targeting platelets for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790 · cited 1×
“This study randomly assigned 13,608 patients with moderate-to-high-risk acute coronary syndromes to prasugrel or clopidogrel (Wiviott et al., 2007).”
Background(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Heng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, L., Kereiakes, D. J., Yeh, R. W., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Normand, S.-L. T., Braunwald, E., Wiviott, S. D., Cohen, D. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409312 · Cited by 1,928
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
The Nature and Significance of Platelet Products in Human Plasma
Wolf, P. (1967) · British Journal of Haematology · doi:10.1111/j.1365-2141.1967.tb08741.x · Cited by 1,720
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Geuze, H. J., & Sixma, J. J. (1999) · Blood · doi:10.1182/blood.v94.11.3791 · Cited by 1,487
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Hooper, C., Laurence, I., Harvey, J., Morley, A., Darby, M., Edey, A., & Maskell, N. (2014) · Respiration · doi:10.1159/000347003 · Cited by 1,184
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Motz, G. T., Santoro, S. P., Wang, L.-P., Garrabrant, T., Lastra, R. R., Hagemann, I. S., Lal, P., Feldman, M. D., Benencia, F., & Coukos, G. (2014) · Nature Medicine · doi:10.1038/nm.3541 · Cited by 1,035
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., & Degen, J. L. (2005) · Blood · doi:10.1182/blood-2004-06-2272 · Cited by 999
Burn, J., Gerdes, A.-M., Macrae, F., Mecklin, J.-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61049-0 · Cited by 952
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Crizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611770 · Cited by 914
Italiano, J. E., Richardson, J. L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., Ryeom, S., Folkman, J., & Klement, G. L. (2008) · Blood · doi:10.1182/blood-2007-09-113837 · Cited by 859
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 843
Rothwell, P. M., Price, J. F., Fowkes, F. G. R., Zanchetti, A., Roncaglioni, M. C., Tognoni, G., Lee, R., Belch, J. F., Wilson, M., Mehta, Z., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61720-0 · Cited by 839
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt, B., Hafner, M., Echtenacher, B., & Männel, D. N. (1999) · PubMed · Cited by 832
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831
Paraneoplastic thrombocytosis in ovarian cancer
Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110352 · Cited by 812
Self-citationAntimetastatic effects associated with platelet reduction.
Gasic, G. J., Gasic, T. B., & Stewart, C. C. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.1.46 · Cited by 720
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L., & Rafii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.663 · Cited by 713
The platelet contribution to cancer progression
BAMBACE, N. M., & HOLMES, C. E. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04131.x · Cited by 705
BLOM, J. W., VANDERSCHOOT, J. P. M., OOSTINDIËR, M. J., OSANTO, S., VAN DER MEER, F. J. M., & ROSENDAAL, F. R. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01804.x · Cited by 692
Kakkar, A. K., Levine, M. N., Kadziola, Z., Lemoine, N. R., Low, V., Patel, H. K., Rustin, G., Thomas, M., Quigley, M., & Williamson, R. C. N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.002 · Cited by 650
Jin, D. K., Shido, K., Kopp, H.-G., Petit, I., Shmelkov, S. V., Young, L. M., Hooper, A. T., Amano, H., Avecilla, S. T., Heissig, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1400 · Cited by 646
Schumacher, D., Strilic, B., Sivaraj, K. K., Wettschureck, N., & Offermanns, S. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.008 · Cited by 630
Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events
Baum, C. L., & Arpey, C. J. (2006) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31612 · Cited by 602
The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy
Klerk, C. P. W., Smorenburg, S. M., Otten, H.-M., Lensing, A. W. A., Prins, M. H., Piovella, F., Prandoni, P., Bos, M. M. E. M., Richel, D. J., van Tienhoven, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.134 · Cited by 596
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., Sanchez, J., & Olson, R. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.058 · Cited by 566
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H. (2005) · Cancer · doi:10.1002/cncr.21496 · Cited by 565
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, A. T. (2009) · JAMA · doi:10.1001/jama.2009.1112 · Cited by 557
Platelets guide the formation of early metastatic niches
Labelle, M., Begum, S., & Hynes, R. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411082111 · Cited by 555
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Khorana, A. A., & Connolly, G. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3271 · Cited by 539
Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H., & Ozaki, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702327200 · Cited by 519
Kopp, H.-G., Placke, T., & Salih, H. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2123 · Cited by 469
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
Selectins promote tumor metastasis
Läubli, H., & Borsig, L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.005 · Cited by 461
Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H.-G., Kopp, H.-G., & Salih, H. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1872 · Cited by 458
P-selectin deficiency attenuates tumor growth and metastasis
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9325 · Cited by 454
Lee, A. Y. Y., Rickles, F. R., Julian, J. A., Gent, M., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., & Levine, M. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.133 · Cited by 453
Fabre, J.-E., Nguyen, M., Latour, A., Keifer, J. A., Audoly, L. P., Coffman, T. M., & Koller, B. H. (1999) · Nature Medicine · doi:10.1038/13522 · Cited by 439
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
Wan, J., Nguyen, N., & Sallah, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613051 · Cited by 411
Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events
Baum, C. L., & Arpey, C. J. (2005) · Dermatologic Surgery · doi:10.1097/00042728-200506000-00011 · Cited by 404
Kim, H. K., Song, K. S., Park, Y. S., Kang, Y. H., Lee, Y. J., Lee, K. R., Kim, H. K., Ryu, K. W., Bae, J. M., & Kim, S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00596-8 · Cited by 401
Blood platelets contain tumor-derived RNA biomarkers
Nilsson, R. J. A., Balaj, L., Hulleman, E., van Rijn, S., Pegtel, D. M., Walraven, M., Widmark, A., Gerritsen, W. R., Verheul, H. M., Vandertop, W. P., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344408 · Cited by 399
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
Camerer, E., Qazi, A. A., Duong, D. N., Cornelissen, I., Advincula, R., & Coughlin, S. R. (2004) · Blood · doi:10.1182/blood-2004-02-0434 · Cited by 386
Battinelli, E. M., Markens, B. A., & Italiano, J. E. (2011) · Blood · doi:10.1182/blood-2011-02-334524 · Cited by 365
Janowska-Wieczorek, A., Majka, M., Kijowski, J., Baj-Krzyworzeka, M., Reca, R., Turner, A. R., Ratajczak, J., Emerson, S. G., Kowalska, M. A., & Ratajczak, M. Z. (2001) · Blood · doi:10.1182/blood.v98.10.3143 · Cited by 354
Platelets actively sequester angiogenesis regulators
Lakka Klement, G., Yip, T.-T., Cassiola, F., Kikuchi, L., Cervi, D., Podust, V., Italiano, J. E., Wheatley, E., Abou-Slaybi, A., Bender, E., et al. (2009) · Blood · doi:10.1182/blood-2008-06-159541 · Cited by 346
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Rachidi, S., Metelli, A., Riesenberg, B., Wu, B. X., Nelson, M. H., Wallace, C., Paulos, C. M., Rubinstein, M. P., Garrett-Mayer, E., Hennig, M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai7911 · Cited by 335
Novel drug development opportunities for heparin
Lever, R., & Page, C. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd724 · Cited by 328
Platelet microparticles induce angiogenesis in vitro
Kim, H. K., Song, K. S., Chung, J., Lee, K. R., & Lee, S. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04773.x · Cited by 328
Flaumenhaft, R., Dilks, J. R., Richardson, J., Alden, E., Patel-Hett, S. R., Battinelli, E., Klement, G. L., Sola-Visner, M., & Italiano, J. E. (2009) · Blood · doi:10.1182/blood-2008-06-163832 · Cited by 317
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
Herzog, B. H., Fu, J., Wilson, S. J., Hess, P. R., Sen, A., McDaniel, J. M., Pan, Y., Sheng, M., Yago, T., Silasi-Mansat, R., et al. (2013) · Nature · doi:10.1038/nature12501 · Cited by 317
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles
Li, J., Ai, Y., Wang, L., Bu, P., Sharkey, C. C., Wu, Q., Wun, B., Roy, S., Shen, X., & King, M. R. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.046 · Cited by 313
Nomura, S., Tandon, N. N., Nakamura, T., Cone, J., Fukuhara, S., & Kambayashi, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00433-6 · Cited by 304
Uhrin, P., Zaujec, J., Breuss, J. M., Olcaydu, D., Chrenek, P., Stockinger, H., Fuertbauer, E., Moser, M., Haiko, P., Fässler, R., et al. (2010) · Blood · doi:10.1182/blood-2009-04-216069 · Cited by 297
Hron, G., Kollars, M., Weber, H., Sagaster, V., Quehenberger, P., Eichinger, S., Kyrle, P. A., & Weltermann, A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-03-0141 · Cited by 296
Thrombocytosis Associated With Malignant Disease
LEVIN, J. (1964) · Archives of Internal Medicine · doi:10.1001/archinte.1964.03860100079008 · Cited by 295
Isolation of human platelet membrane microparticles from plasma and serum
George, J., Thoi, L., McManus, L., & Reimann, T. (1982) · Blood · doi:10.1182/blood.v60.4.834.834 · Cited by 293
Poor prognosis associated with thrombocytosis in patients with gastric cancer
Ikeda, M., Furukawa, H., Imamura, H., Shimizu, J., Ishida, H., Masutani, S., Tatsuta, M., & Satomi, T. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02573067 · Cited by 292
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
Haemmerle, M., Taylor, M. L., Gutschner, T., Pradeep, S., Cho, M. S., Sheng, J., Lyons, Y. M., Nagaraja, A. S., Dood, R. L., Wen, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00411-z · Cited by 274
Self-citationWiltrout, R. H., Herberman, R. B., Zhang, S. R., Chirigos, M. A., Ortaldo, J. R., Green, K. M., & Talmadge, J. E. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.4267 · Cited by 272
Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth
Michael, J. V., Wurtzel, J. G. T., Mao, G. F., Rao, A. K., Kolpakov, M. A., Sabri, A., Hoffman, N. E., Rajan, S., Tomar, D., Madesh, M., et al. (2017) · Blood · doi:10.1182/blood-2016-11-751099 · Cited by 252
Platelets increase the proliferation of ovarian cancer cells
Cho, M. S., Bottsford-Miller, J., Vasquez, H. G., Stone, R., Zand, B., Kroll, M. H., Sood, A. K., & Afshar-Kharghan, V. (2012) · Blood · doi:10.1182/blood-2012-06-438598 · Cited by 245
Self-citationUngerer, M., Rosport, K., Bültmann, A., Piechatzek, R., Uhland, K., Schlieper, P., Gawaz, M., & Münch, G. (2011) · Circulation · doi:10.1161/circulationaha.110.980623 · Cited by 245
Biased Signaling of Protease-Activated Receptors
Zhao, P., Metcalf, M., & Bunnett, N. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00067 · Cited by 245
Ma, L., Elliott, S. N., Cirino, G., Buret, A., Ignarro, L. J., & Wallace, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111150798 · Cited by 244
Platelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Prognostic significance of thrombocytosis in patients with primary lung cancer
Pedersen, L., & Milman, N. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09091826 · Cited by 232
Platelet Granule Secretion Continuously Prevents Intratumor Hemorrhage
Ho-Tin-Noé, B., Goerge, T., Cifuni, S. M., Duerschmied, D., & Wagner, D. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0718 · Cited by 229
Nucleotide receptor signaling in platelets
KAHNER, B. N., SHANKAR, H., MURUGAPPAN, S., PRASAD, G. L., & KUNAPULI, S. P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02192.x · Cited by 219
Dorff, T. B., Goldman, B., Pinski, J. K., Mack, P. C., Lara, P. N., Van Veldhuizen, P. J., Quinn, D. I., Vogelzang, N. J., Thompson, I. M., & Hussain, M. H. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3122 · Cited by 212
Platelets in tissue repair: control of apoptosis and interactions with regenerative cells
Gawaz, M., & Vogel, S. (2013) · Blood · doi:10.1182/blood-2013-05-468694 · Cited by 210
Trikha, M., Zhao, Z., Tı́már, J., Raso, E., Kennel, M., Emmell, E., & Nakada, M. T. (2002) · PubMed · Cited by 210
Burnouf, T., Goubran, H. A., Chou, M.-L., Devos, D., & Radosevic, M. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.04.002 · Cited by 210
Glycosylation Changes in Cancer
Varki, A. P., Kannagi, R., Toole, B. P., & Stanley, P. (2009) · doi:10.1101/glycobiology.3e.047 · Cited by 209
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
Hettiarachchi, R., Smorenburg, S., Ginsberg, J., Levine, M., Prins, M., & Büller, H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615937 · Cited by 206
Takagi, S., Sato, S., Oh-hara, T., Takami, M., Koike, S., Mishima, Y., Hatake, K., & Fujita, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073609 · Cited by 204
Meyer, A., Wang, W., Qu, J., Croft, L., Degen, J. L., Coller, B. S., & Ahamed, J. (2012) · Blood · doi:10.1182/blood-2011-09-377648 · Cited by 203
TGF-β in blood: a complex problem
Grainger, D. J., Mosedale, D. E., & Metcalfe, J. C. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00037-4 · Cited by 202
Nilsson, R. J. A., Karachaliou, N., Berenguer, J., Gimenez-Capitan, A., Schellen, P., Teixido, C., Tannous, J., Kuiper, J. L., Drees, E., Grabowska, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6279 · Cited by 202
Liang, H., Yan, X., Pan, Y., Wang, Y., Wang, N., Li, L., Liu, Y., Chen, X., Zhang, C.-Y., Gu, H., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0327-z · Cited by 200
Platelet glycoprotein Ibα supports experimental lung metastasis
Jain, S., Zuka, M., Liu, J., Russell, S., Dent, J., Guerrero, J. A., Forsyth, J., Maruszak, B., Gartner, T. K., Felding-Habermann, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700625104 · Cited by 197
Egan, K., Crowley, D., Smyth, P., O'Toole, S., Spillane, C., Martin, C., Gallagher, M., Canney, A., Norris, L., Conlon, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026125 · Cited by 181
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis
TESSELAAR, M. E. T., ROMIJN, F. P. H. T. M., VAN DER LINDEN, I. K., BERTINA, R. M., & OSANTO, S. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03504.x · Cited by 179
Macbeth, F., Noble, S., Evans, J., Ahmed, S., Cohen, D., Hood, K., Knoyle, D., Linnane, S., Longo, M., Moore, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0268 · Cited by 178
Formation of procoagulant microparticles and properties
Freyssinet, J., & Toti, F. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.036 · Cited by 166
Rossi, J.-F., Négrier, S., James, N. D., Kocak, I., Hawkins, R., Davis, H., Prabhakar, U., Qin, X., Mulders, P., & Berns, B. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605872 · Cited by 166
Fox, J. E., Austin, C. D., Boyles, J. K., & Steffen, P. K. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.483 · Cited by 166
Cauwenberghs, S., Feijge, M. A. H., Harper, A. G. S., Sage, S. O., Curvers, J., & Heemskerk, J. W. M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.082 · Cited by 159
Cecchetti, L., Tolley, N. D., Michetti, N., Bury, L., Weyrich, A. S., & Gresele, P. (2011) · Blood · doi:10.1182/blood-2010-12-324517 · Cited by 156
Impact of pretreatment thrombocytosis on survival in primary breast cancer
Salat, A., Gnant, M., Kwasny, W., Mlineritsch, B., Menzel, R.-C., Schmid, M., Smola, M. G., Stierer, M., Tausch, C., Galid, A., et al. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613413 · Cited by 156
Elwood, P. C., Morgan, G., Pickering, J. E., Galante, J., Weightman, A. L., Morris, D., Kelson, M. J., & Dolwani, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152402 · Cited by 154
Versteeg, H. H., Schaffner, F., Kerver, M., Ellies, L. G., Andrade‐Gordon, P., Mueller, B. M., & Ruf, W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0419 · Cited by 147
Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin
Dinkla, S., van Cranenbroek, B., van der Heijden, W. A., He, X., Wallbrecher, R., Dumitriu, I. E., van der Ven, A. J. A. M., Bosman, G. J. C. G. M., Koenen, H. J. P. M., & Joosten, I. (2016) · Blood · doi:10.1182/blood-2015-04-640300 · Cited by 145
P2Y12 platelet inhibition in clinical practice
Damman, P., Woudstra, P., Kuijt, W. J., de Winter, R. J., & James, S. K. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0667-5 · Cited by 140
Danckwardt, S., Hentze, M. W., & Kulozik, A. E. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1074-5 · Cited by 139
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
Hämmerle, M., Bottsford-Miller, J. N., Pradeep, S., Taylor, M., Choi, H. J., Hansen, J. M., Dalton, H. J., Stone, R. L., Cho, M. S., Nick, A. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85086 · Cited by 134
Self-citationPlatelet integrin α6β1 controls lung metastasis through direct binding to cancer cell–derived ADAM9
Mammadova‐Bach, E., Zigrino, P., Brucker, C., Bourdon, C., Freund, M., Arcangelis, A. D., Abrams, S. I., Orend, G., Gachet, C., & Mangin, P. (2016) · JCI Insight · doi:10.1172/jci.insight.88245 · Cited by 134
Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models
Jain, S., Russell, S., & Ware, J. L. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03559.x · Cited by 127
Inhibition of Platelet Function: Does It Offer a Chance of Better Cancer Progression Control?
Sierko, E., & Wojtukiewicz, M. Z. (2007) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-991540 · Cited by 125
Azab, A. K., Quang, P., Azab, F., Pitsillides, C. M., Thompson, B. D., Chonghaile, T. N., Patton, J. T., Maiso, P., Monrose, V., Sacco, A., et al. (2011) · Blood · doi:10.1182/blood-2011-07-368050 · Cited by 125
Role of ADP receptors on platelets in the growth of ovarian cancer
Cho, M. S., Noh, K., Hämmerle, M., Li, D., Park, H., Hu, Q., Hisamatsu, T., Mitamura, T., Mak, S. L. C., Kunapuli, S. P., et al. (2017) · Blood · doi:10.1182/blood-2017-02-769893 · Cited by 123
Self-citationLectures on Clinical Medicine, Delivered at the Hotel-Dieu, Paris
Trousseau, A., Bazire, P., & Cormack, J. R. (2010) · Medical Entomology and Zoology · Cited by 120
Dovizio, M., Maier, T. J., Alberti, S., Francesco, L. D., Marcantoni, E., Münch, G., John, C. M., Suess, B., Sgambato, A., Steinhilber, D., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084988 · Cited by 120
Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis
Wang, Y., Sun, Y., Li, D., Zhang, L., Wang, K., Zuo, Y., Gartner, T. K., & Liu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080780 · Cited by 114
Platelets Take Up the Monoclonal Antibody Bevacizumab
Verheul, H. M. W., Lolkema, M. P., Qian, D. Z., Hilkes, Y. H. A., Liapi, E. A., Akkerman, J. N., Пили, Р., & Voest, E. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0847 · Cited by 113
Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer
Hu, Q., Hisamatsu, T., Hämmerle, M., Cho, M. S., Pradeep, S., Rupaimoole, R., Rodriguez‐Aguayo, C., Lopez‐Berestein, G., Wong, S. T. C., Sood, A. K., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3272 · Cited by 113
Self-citationPlatelets: Guardians of Tumor Vasculature
Ho‐Tin‐Noé, B., Goerge, T., & Wagner, D. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1370 · Cited by 111
Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
Bottsford-Miller, J. N., Choi, H. J., Dalton, H. J., Stone, R. L., Cho, M. S., Hämmerle, M., Nick, A. M., Pradeep, S., Zand, B., Previs, R. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0870 · Cited by 110
Self-citationCell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease
Gurbel, P. A., Bliden, K. P., Turner, S. E., Tantry, U. S., Gesheff, M. G., Barr, T. P., Covic, L., & Kuliopulos, A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306777 · Cited by 110
Presence of intratumoral platelets is associated with tumor vessel structure and metastasis
Li, R., Ren, M., Chen, N., Luo, M., Deng, X., Xia, J., Yu, G., Liu, J., He, B., Zhang, X., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-167 · Cited by 108
Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
Reimers, M. S., Bastiaannet, E., Langley, R. E., van Eijk, R., van Vlierberghe, R. L. P., Lemmens, V. E. P. P., van Herk‐Sukel, M. P. P., van Wezel, T., Fodde, R., Kuppen, P. J. K., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.511 · Cited by 107
Platelets govern pre-metastatic tumor communication to bone
Kerr, B. A., McCabe, N. P., Feng, W., & Byzova, T. V. (2012) · Oncogene · doi:10.1038/onc.2012.447 · Cited by 102
Innate Immune Cells Induce Hemorrhage in Tumors during Thrombocytopenia
Ho‐Tin‐Noé, B., Carbó, C., Demers, M., Cifuni, S. M., Goerge, T., & Wagner, D. D. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090460 · Cited by 101
The tumour trail left in blood
Chi, K. R. (2016) · Nature · doi:10.1038/532269a · Cited by 99
Eichinger, S., Heinze, G., & Kyrle, P. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000467 · Cited by 97
The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets
Bambace, N. M., Levis, J. E., & Holmes, C. E. (2010) · Platelets · doi:10.3109/09537100903470298 · Cited by 95
P-selectin-mediated platelet adhesion promotes tumor growth
Qi, C., Wei, B., Zhou, W., Yang, Y., Li, B., Guo, S., Li, J., Ye, J., Li, J., Zhang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3164 · Cited by 89
Increased Efficacy of Breast Cancer Chemotherapy in Thrombocytopenic Mice
Demers, M., Ho‐Tin‐Noé, B., Schatzberg, D., Yang, J. J., & Wagner, D. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2038 · Cited by 88
Platelets induce apoptosis via membrane-bound FasL
Schleicher, R., Reichenbach, F., Kraft, P., Kumar, A., Lescan, M., Todt, F., Göbel, K., Hilgendorf, I., Geisler, T., Bauer, A., et al. (2015) · Blood · doi:10.1182/blood-2013-12-544445 · Cited by 87
Dilly, A. K., Ekambaram, P., Guo, Y., Cai, Y., Tucker, S. C., Fridman, R. A., Kandouz, M., & Honn, K. V. (2013) · International Journal of Cancer · doi:10.1002/ijc.28165 · Cited by 84
Protection from tumor necrosis factor-mediated cytolysis by platelets.
Philippe, C., Philippe, B., Fouqueray, B. L., Perez, J., Lebret, M., & Baud, L. (1993) · PubMed Central · Cited by 83
Radziwon‐Balicka, A., Medina, C., O’Driscoll, L., Treumann, A., Bazou, D., Inkielewicz‐Stępniak, I., Radomski, A. D., Jow, H., & Radomski, M. W. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01991.x · Cited by 82
Current State and Novel Approaches of Antiplatelet Therapy
Metharom, P., Berndt, M. C., Baker, R. I., & Andrews, R. K. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303413 · Cited by 79
Wang, R., Stone, R. L., Kaelber, J. T., Rochat, R. H., Nick, A. M., Vijayan, K. V., Afshar‐Kharghan, V., Schmid, M. F., Dong, J., Sood, A. K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518628112 · Cited by 76
Self-citationHow useful is thrombocytosis in predicting an underlying cancer in primary care? a systematic review
Bailey, S. E. R., Ukoumunne, O. C., Shephard, E. A., & Hamilton, W. T. (2016) · Family Practice · doi:10.1093/fampra/cmw100 · Cited by 75
Salanova, B., Choi, M., Rolle, S., Wellner, M., Luft, F. C., & Kettritz, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704039200 · Cited by 73
Targeting von Willebrand factor and platelet glycoprotein Ib receptor
Firbas, C., Siller-Matula, J. M., & Jilma, B. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.154 · Cited by 71
Coghill, A. E., Newcomb, P. A., Campbell, P. T., Burnett‐Hartman, A. N., Adams, S. V., Poole, E. M., Potter, J. D., & Ulrich, C. M. (2010) · Gut · doi:10.1136/gut.2010.221143 · Cited by 67
The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence
Leader, A., Zelikson-Saporta, R., Pereg, D., Spectre, G., Rozovski, U., Raanani, P., Hermoni, D., & Lishner, M. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.01.022 · Cited by 67
Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms
Zhang, N., Lou, W., Ji, F., Qiu, L., Tsang, B. K., & Di, W. J. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2131-6 · Cited by 59
Zhang, W., Dang, S., Hong, T., Tang, J., Fan, J., Bu, D., Sun, Y., Wang, Z., & Wısnıewskı, T. (2012) · Blood · doi:10.1182/blood-2012-04-425207 · Cited by 58
Increased platelet reactivity in patients with late‐stage metastatic cancer
Cooke, N. M., Egan, K., McFadden, S., Grogan, L., Breathnach, O. S., O’Leary, J. J., Hennessy, B. T., & Kenny, D. J. (2013) · Cancer Medicine · doi:10.1002/cam4.86 · Cited by 58
Riedl, J., Kaider, A., Marosi, C., Prager, G. W., Eichelberger, B., Assinger, A., Pabinger, I., Panzer, S., & Ay, C. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-02-0123 · Cited by 54
Crosstalk between platelets and PBMC: New evidence in wound healing
Nami, N., Feci, L., Napoliello, L., Giordano, A., Lorenzini, S., Galeazzi, M., Rubegni, P., & Fimiani, M. (2015) · Platelets · doi:10.3109/09537104.2015.1048216 · Cited by 43
de Leval, X., Benoît, V., Delarge, J., Julémont, F., Masereel, B., Pirotte, B., Merville, M.-P., David, J., & Dogné, J. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(02)00235-1 · Cited by 43
P-Selectin-Mediated Platelet Adhesion Promotes the Metastasis of Murine Melanoma Cells
Qi, C., Wei, B., Ye, J., Yang, Y., Li, B., Zhang, Q., Li, J., He, X., Lan, T., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091320 · Cited by 41
Pharmacological Regulation of Platelet Factors That Influence Tumor Angiogenesis
Yan, M., Lesyk, G. M., Radziwon‐Balicka, A., & Jurasz, P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.04.007 · Cited by 35
Proteinase-activated receptors (PARs) as targets for antiplatelet therapy
Cunningham, M., McIntosh, K., Bushell, T. J., Sloan, G., & Plevin, R. J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150282 · Cited by 19
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L., & Heikenwalder, M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 616
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Immunobiology and pathogenesis of hepatitis B virus infection
Iannacone, M., & Guidotti, L. G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00549-4 · Cited by 520
Bach, D.-H., Lee, S. K., & Sood, A. K. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.02.005 · Cited by 405
Self-citation
Metadata
- Authors
- Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V., & Sood, A. K.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 33
- Issue
- 6
- Pages
- 965-983
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2797421660
- Cited by
- 638
- References
- 153
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.